menu
    • menu

    Company profile for SAFC

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SAFC is the custom manufacturing and services business unit of Sigma-Aldrich Corporation. The Company is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global “Centers of Excellence” and dedicated manuf...
    SAFC is the custom manufacturing and services business unit of Sigma-Aldrich Corporation. The Company is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global “Centers of Excellence” and dedicated manufacturing facilities. SAFC is committed to being the preferred global supplier of raw materials for development and manufacturing within the life science and high technology industries. We strive to bring our customers relevant solutions and quality products that exceed expectations and grow their business through our customer intimate approach. SAFC endeavors to be at the forefront of helping customers make products that matter and make a difference.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SAFCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3050 Spruce Street, St. Louis, MO 63103
    Telephone
    Telephone
    +1 314 289 8454
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sigma-aldrich.com/safc.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI Japan

    Not Confirmed

    envelop Contact Supplier

    CPhI Japan

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 794

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

    Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

    This week, we delve into molecular glue degraders (MGDs), one of the most promising frontiers in drug development. MGDs address a vast number of previously “undruggable” disease-causing proteins.Unlike traditional small molecule drugs that require specific binding pockets, MGDs function by enhancing protein-protein interactions. MGDs selectively target disease-causing proteins and an enzyme known as E3 ubiquitin ligase. By creating a binding interface between the two, MGDs  destroy the target proteins.Another kind of degraders are proteolysis targeting chimeras (PROTACs) that use a bifunctional approach — one binds the target proteins, and the other binds to an E3 ligases together. These degraders induce the degradation of specific proteins by using the cell’s natural ubiquitin-proteasome system (a process in cells where damaged or unneeded proteins are tagged by a small molecule called ubiquitin and then broken down by a structure called the proteasome so that cells stay healthy and function properly).MGDs constitute a rapidly growing market, where both the targeted protein degradation technologies and investment in research and development are witnessing growth.Currently, the most recognized molecular glues are the immunomodulatory imide drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, which have been around for some time. According to GlobalData, lenalidomide generated over US$ 6 billion in sales in 2023, thereby demonstrating the commercial viability of this therapeutic approach.Lilly, AbbVie ink billion-dollar MGD deals; Biogen partners Neomorph; Pfizer, Triana ink collaborationThe MGD space has witnessed extraordinary deal-making activity over the recent months, with major pharmaceutical companies committing billions of dollars to secure access to novel MGD platforms and pipelines. This surge in investment reflects the industry’s growing confidence in the therapeutic potential of MGDs to address previously undruggable targets.This year has already seen two landmark deals. In February, Magnet Biomedicine entered into a collaboration and license agreement with Eli Lilly worth up to US$ 1.29 billion to discover and develop novel MGDs. This partnership leverages Magnet’s TrueGlue discovery platform and approach with Lilly’s expertise in the development of small molecule therapeutics. In January, AbbVie crafted a US$ 1.64 billion deal with molecular glue biotech Neomorph, combining AbbVie’s oncology and immunology drug development capabilities with Neomorph's leading molecular glue discovery platform.While oncology remains the primary focus, these collaborations are increasingly expanding into neurodegenerative diseases, immunological disorders, and other therapeutic areas. For instance, in October, Biogen and Neomorph announced a multi-target research collaboration to discover and develop MGDs for Alzheimer’s, rare neurological, and immunological diseases, potentially worth up to US$ 1.45 billion.October also saw Novartis sign a potential US$ 2.25 billion deal with Monte Rosa Therapeutics. The deal gives Novartis exclusive worldwide rights to develop, manufacture and commercialize multiple MGDs (including MRT-6160) for undruggable targets, including in the areas of immunology and inflammation, metabolism, and genetic diseases.Earlier in October, Triana Biomedicines and Pfizer entered into a research collaboration to discover novel MGDs for multiple targets across several disease areas, including oncology, with a total potential value of up to US$ 1.55 billion.And in August 2024, SEED Therapeutics entered into a strategic research collaboration with Eisai to discover and develop novel MGDs for neurodegenerative and oncological indications, potentially worth up to US$ 1.5 billion.BMS leads with three MGDs in late-stage trials; Monte Rosa’s MRT-2359 targets solid tumorsBristol Myers Squibb has established itself as a leader in the clinical development of MGDs with three products in late-stage development. These include a next-gen MGD mezigdomide (CC-92480), which is currently in phase 3 trials in combination with carfilzomib and dexamethasone for relapsed/refractory multiple myeloma. Another candidate is golcadomide, which is in late-stage clinical trials for high-risk first-line large B-cell lymphoma. And the third MGD in BMS’ portfolio is iberdomide, which has reached phase 3 development for multiple myeloma.Monte Rosa Therapeutics has made significant progress with MRT-2359, an investigational MGD that is currently in phase 1/2 clinical trials for the treatment of patients with MYC-driven solid tumors, including non-small cell lung cancer, small cell lung cancer, and high-grade neuroendocrine cancer. Myelocytomatosis or MYC is a gene which causes various solid tumors when overactive.MRT-2359 represents an important advancement in extending the molecular glue approach beyond hematological malignancies to solid tumors, which have historically proven more challenging to address with protein degradation strategies.Other significant early-stage candidates are Nested Therapeutics’ NST-628 and Plexium's PLX-4545. NST-628 relies on a novel mechanism of action in its category of RAS-MAPK inhibitors, and overcomes some traditional limitations in the treatment of cancers.PLX-4545 is Plexium’s first small molecule degrader program to enter clinical development. This potent and selective MGD of a classically undruggable transcription factor, also known as Helios (IKZF2), explores treating solid tumors. Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences.Boehringer’s KRAS degrader advances PROTACs approach; Arvinas tests ARV-102 for neurodegenerative diseasesLike MGDs, PROTACs are also witnessing advancements in both R&D and dealmaking. For instance, BridGene Biosciences recently expanded its strategic collaboration with Galapagos to develop a selective oral SMARCA2 PROTAC in precision oncology. The SMARCA2 gene provides instructions for making one piece (subunit) of a group of similar protein complexes known as SWI/SNF complexes.In the clinical arena, Prelude Therapeutics announced a collaboration with Merck to evaluate PRT3789 in combination with Keytruda (pembrolizumab) in patients with SMARCA4-mutated cancers. PRT3789 is a potent and highly selective, first-in-class SMARCA2 degrader.On the molecular front, ACBI3, a novel pan-KRAS degrader developed through a collaboration between the University of Dundee and Boehringer Ingelheim, addresses a critical gap in cancer therapy by targeting 13 out of 17 prevalent KRAS mutants. KRAS mutation is a change in the KRAS gene, a common gene that can cause cancer. ACBI3’s development is a potential breakthrough for millions of cancer patients with KRAS-driven tumors.Vepdegestrant (ARV-471), a collaborative effort between Arvinas and Pfizer, remains the most advanced PROTAC candidate to date and has met its primary endpoint in a late-stage study in breast cancer patients with estrogen receptor 1 mutations.  Similarly, Arvinas’ ARV-102 became the first PROTAC to be tested in humans for neurodegenerative diseases, marking a significant milestone in addressing brain-related disorders.Our viewMGDs offer a new, and groundbreaking approach to treating cancers and various other diseases, thereby attracting substantial investments by major pharmaceutical companies. As clinical trials show encouraging results, we expect investments in the MGDs space to increase even further. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 313

    https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs

    #Phispers by PHARMACOMPASS
    27 Mar 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy

    14 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/German-Merck-announces-EU-plant-cuts-and-consolidation-plan

    G. MacDonald IN PHARMATECHNOLOGIST
    14 Jul 2017
    Share Share
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine

    07 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/EC-says-Merck-and-Sigma-Aldrich-broke-M-A-procedures

    G. MacDonald IN PHARMATECHNOLOGIST
    07 Jul 2017
    Share Share
    Improving solubility: MilliporeSigma opens dedicated meglumine site
    Improving solubility: MilliporeSigma opens dedicated meglumine site

    19 Jan 2017

    // Dan Stanton IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Improving-solubility-MilliporeSigma-opens-dedicated-meglumine-site

    Dan Stanton IN PHARMATECHNOLOGIST
    19 Jan 2017
    Share Share
    MilliporeSigma Expands Distribution Agreement with Roche in Canada
    MilliporeSigma Expands Distribution Agreement with Roche in Canada

    01 Dec 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/milliporesigma-expands-distribution-agreement-with-roche-in-canada-300367603.html

    PR NEWSWIRE
    01 Dec 2016
    Share Share
    Honeywell Launces New Research Chemicals Business
    Honeywell Launces New Research Chemicals Business

    29 Nov 2016

    // DRUG DEVELOPMENT

    http://www.drug-dev.com/Main/Current-News/Honeywell-Launces-New-Research-Chemicals-Business-1770.aspx

    DRUG DEVELOPMENT
    29 Nov 2016
    Share Share
    Merck's pharma unit faces tougher 2017 as fertility boost recedes
    Merck's pharma unit faces tougher 2017 as fertility boost recedes

    17 Nov 2016

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/mercks_pharma_unit_faces_tougher_2017_as_fertility_boost_recedes_1176998

    Phil Taylor PMLIVE
    17 Nov 2016
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Benzyl Alcohol API

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Benzyl Alcohol API

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-24

    Pay. Date : 2013-04-09

    DMF Number : 27017

    Submission : 2013-03-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2016-136 - Rev 01

    Issue Date : 2024-02-05

    Type : Chemical

    Substance Number : 256

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Clomipramine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Clomipramine Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-03-11

    Pay. Date : 2014-10-29

    DMF Number : 10949

    Submission : 1994-06-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-269 - Rev 01

    Issue Date : 2016-09-22

    Type : Chemical

    Substance Number : 889

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Dactinomycin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Dactinomycin

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3538

    Submission : 1979-04-03

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 221MF10187

    Registrant's Address : 13 Kiryat Mada Street, Har Hotzvim Industrial Park Jerusalem, 97770 ISRAEL

    Initial Date of Registration : 2009-08-13

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Doxylamine Succinate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Doxylamine Succinate

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 6908

    Submission : 1987-04-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2004-167 - Rev 02

    Issue Date : 2025-01-29

    Type : Chemical

    Substance Number : 1589

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    L-Glutamine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    L-Glutamine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 10565

    Submission : 1993-11-12

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 304MF40011

    Registrant's Address : Second Avenue Heatherhouse Industrial Estate Irvine, Scotland, United Kingdom KA12 8NB

    Initial Date of Registration : 2022-03-10

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Sodium Benzoate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Sodium Benzoate

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-04-27

    Pay. Date : 2014-11-05

    DMF Number : 27608

    Submission : 2013-09-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-144 - Rev 00

    Issue Date : 2022-01-06

    Type : Chemical

    Substance Number : 123

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    L-Glutamine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    L-Glutamine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 11013

    Submission : 1994-08-02

    Status : Inactive

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 304MF40012

    Registrant's Address : 13804 West 107th Street Lenexa, Kansas 66215 USA

    Initial Date of Registration : 2022-03-10

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Sodium Bicarbonate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Sodium Bicarbonate

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16457

    Submission : 2003-02-28

    Status : Inactive

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 230MF40003

    Registrant's Address : 13804 West 107th Street Lenexa, Kansas 66215 USA

    Initial Date of Registration : 2018-01-15

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Glycine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Glycine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 10656

    Submission : 1994-01-07

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Urea API

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ASPEN
    Not Confirmed
    arrow

    Urea API

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 11455

    Submission : 1995-04-17

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact SAFC and get a quotation

    SAFC is a supplier offers 204 products (APIs, Excipients or Intermediates).

    Find a price of Benzyl Alcohol API bulk with DMF, CEP offered by SAFC

    Find a price of Clomipramine Hydrochloride bulk with DMF, CEP offered by SAFC

    Find a price of Dactinomycin bulk with DMF, JDMF offered by SAFC

    Find a price of Doxylamine Succinate bulk with DMF, CEP offered by SAFC

    Find a price of L-Glutamine bulk with DMF, JDMF offered by SAFC

    Find a price of Sodium Benzoate bulk with DMF, CEP offered by SAFC

    Find a price of L-Glutamine bulk with JDMF offered by SAFC

    Find a price of Sodium Bicarbonate bulk with JDMF offered by SAFC

    Find a price of Aprotinin bulk with CEP offered by SAFC

    Find a price of Bovine Serum bulk with CEP offered by SAFC

    Find a price of Brompheniramine Maleate bulk with DMF offered by SAFC

    Find a price of Catalase bulk with CEP offered by SAFC

    Find a price of Cholic Acid bulk with DMF offered by SAFC

    Find a price of Chymotrypsin bulk with CEP offered by SAFC

    Find a price of Dodecyl Maltoside bulk with DMF offered by SAFC

    Find a price of DPPC bulk with DMF offered by SAFC

    Find a price of Ethanol bulk with DMF offered by SAFC

    Find a price of Glucarpidase bulk with CEP offered by SAFC

    Find a price of Glucose bulk with JDMF offered by SAFC

    Find a price of Glycine bulk with DMF offered by SAFC

    Find a price of Hyaluronidase bulk offered by SAFC

    Find a price of L-Carnosine bulk with CEP offered by SAFC

    Find a price of L-Glutamine bulk with DMF offered by SAFC

    Find a price of L-Tyrosine API bulk with JDMF offered by SAFC

    Find a price of Levothyroxine Sodium bulk with DMF offered by SAFC

    Find a price of Lysine Hydrochloride bulk with DMF offered by SAFC

    Find a price of Maytansinoid DM1 bulk with DMF offered by SAFC

    Find a price of Mebrofenin bulk with DMF offered by SAFC

    Find a price of Nortriptyline bulk with DMF offered by SAFC

    Find a price of Palmitic Acid Chloride bulk with DMF offered by SAFC

    Find a price of Sodium Metaarsenite bulk with DMF offered by SAFC

    Find a price of Sulfo-Smcc bulk with DMF offered by SAFC

    Find a price of Tripalmitin bulk with DMF offered by SAFC

    Find a price of Trypan Blue bulk with DMF offered by SAFC

    Find a price of Urea API bulk with DMF offered by SAFC

    Find a price of Vitamin D bulk with DMF offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFICIENT bulk with DMF offered by SAFC

    Find a price of EX-CELL CD HEK293 VIRAL VECTOR MEDIUM bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60258 CHOKO PRODUCTION MEDIUM POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60259, CHOKO STOCK CULTURE MEDIUM POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60274 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60229 bulk with DMF offered by SAFC

    Find a price of MAYTANSINOL-N-METHYL-L-ALANYL ESTER bulk with DMF offered by SAFC

    Find a price of EX-CELL PF CHO PART A (MODIFIED) bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60256 CHOKO FMA POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM 14366C bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60273 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR40118 bulk with DMF offered by SAFC

    Find a price of EX-CELL(TM) 325 PF CHO, SERUM-FREE MEDIUM, PROTEIN FREE bulk with DMF offered by SAFC

    Find a price of QBSF60 MEDIUM PRODUCT NO. 62520 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60257, CHOKO FMB POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60275 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60219 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60234 bulk with DMF offered by SAFC

    Find a price of Media/Medium Additives・EX-CELL EBx PRO-I Serum-Free Media bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 (without glucose) bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・R36 Low B12 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL ACF CHO Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO FMB Powerer bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ CHOKO Production Medium Powerer bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・EX-CELL(R) Basal Medium bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO Stock Culture Medium Powerer bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 221 Feed Powder bulk with JDMF offered by SAFC

    Find a price of Medium / media supplements · EX-CELL (TM) 325 PF CHO Protei n-Free Medium (Modified) bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive R7A-1 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ TE1 bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive R17 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 215 Medium Powder bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMB9 bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・F48 Low B12 no HC bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives: EX-CELL® Advanced CHO Fed-batch Medium bulk with JDMF offered by SAFC

    Find a price of Medium/Medium Additives・EX-CELL EBx PRO-I Serum-Free Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Sigma EX-CELL PF CHO Mediu m (Modified) bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMB8 bulk with JDMF offered by SAFC

    Find a price of Media/Media Additives GS2-N Low B12 No Hydrocort bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Ex-CELL EBx GRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced (TM) Modified bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive EX-CELL (R) 293 Serum-Free Medium for HEK 293 Cells bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives・EX-CELL EBx GRO-I Serum-Free Media bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHO Kit 2 Iron Chelator Solution bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO FMA Powerer bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・EX-CELL(R) Feed Medium bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx GRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・R34B Medium bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · StemlineⅡ Hematopoietic Stem C ell Expansion Medium bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・Trace Element B Solution B (1000X) bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / PER2 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 203 Medium Powder bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-SuppAA-1 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium Additives・Ex-CELL EBx GRO-I Serum-Free Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · C8862: EX-CELL CHO DHFR\n- Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Fatty Acid Supplement bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・40X Insect Cell Feed bulk with JDMF offered by SAFC

    Find a price of Deoxyribonuclease I, Desoxyribonuclease I Crude Lyophilized Powder, Product Number D0876/DN25 and Desoxyribonuclease I Type II, Product Number D4527 bulk with CEP offered by SAFC

    Find a price of Medium / medium additive · CHO Feed Bioreactor Supplement bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL 325 PF CHO Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL (TM) CD Hydrolysate Fusion Animal Coordinate Free, Chemically Defined bulk with JDMF offered by SAFC

    Find a price of Media/Media Additives ・Trace Element E 1000X Solution bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ IMF9-2X bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Sigma EX-CELL 302 Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMF8 bulk with JDMF offered by SAFC

    Find a price of 3-5-Diiodothyropropionic Acid bulk offered by SAFC

    Find a price of 3-Amino-3-3-Chlorophenyl-Propanoic Acid bulk offered by SAFC

    Find a price of Ammonium Tetrathiomolybdate bulk offered by SAFC

    Find a price of Armodafinil bulk offered by SAFC

    Find a price of Bovine Insulin bulk offered by SAFC

    Find a price of Bovine Serum bulk offered by SAFC

    Find a price of Calcipotriol bulk offered by SAFC

    Find a price of Calcitriol bulk offered by SAFC

    Find a price of Camptothecine bulk offered by SAFC

    Find a price of Carbamazepine bulk offered by SAFC

    Find a price of Cetyl Alcohol API bulk offered by SAFC

    Find a price of Cholesterol-3,4-13C2 bulk offered by SAFC

    Find a price of Copper bulk offered by SAFC

    Find a price of Cortisol-9,11,12,12-D4 bulk offered by SAFC

    Find a price of Dextrans bulk offered by SAFC

    Find a price of Fenbendazole bulk offered by SAFC

    Find a price of Galactomannan bulk offered by SAFC

    Find a price of Gentisic Acid bulk offered by SAFC

    Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by SAFC

    Find a price of Halobetasol bulk offered by SAFC

    Find a price of Halofuginone Lactate bulk offered by SAFC

    Find a price of Hexadimethrine Bromide bulk offered by SAFC

    Find a price of Homotaurine bulk offered by SAFC

    Find a price of Hydroxydopamine Hydrobromide bulk offered by SAFC

    Find a price of Iron bulk offered by SAFC

    Find a price of Isobutylmethylxanthine bulk offered by SAFC

    Find a price of Isobutyramide bulk offered by SAFC

    Find a price of Isosulfan Blue bulk offered by SAFC

    Find a price of L-Carnosine bulk offered by SAFC

    Find a price of L-Glutamine bulk offered by SAFC

    Find a price of Mafodotin [Usan] bulk offered by SAFC

    Find a price of Mebrofenin bulk offered by SAFC

    Find a price of Mechlorethamine bulk offered by SAFC

    Find a price of Methacetin-13C bulk offered by SAFC

    Find a price of Methyl Tert-Butyl Ether bulk offered by SAFC

    Find a price of Methylformamide bulk offered by SAFC

    Find a price of Pefcalcitol bulk offered by SAFC

    Find a price of Penicillamine bulk offered by SAFC

    Find a price of Pentamidine Isethionate bulk offered by SAFC

    Find a price of Percorten bulk offered by SAFC

    Find a price of Polygalacturonic Acid bulk offered by SAFC

    Find a price of Promethazine Hydrochloride bulk offered by SAFC

    Find a price of Putrescine Hydrochloride bulk offered by SAFC

    Find a price of Rhodamine 123 bulk offered by SAFC

    Find a price of Sodium Bicarbonate bulk offered by SAFC

    Find a price of Sodium Butyrate bulk offered by SAFC

    Find a price of Sodium Metaarsenite bulk offered by SAFC

    Find a price of Sodium Octanoate-1-13C bulk offered by SAFC

    Find a price of Squalene API bulk offered by SAFC

    Find a price of Thrombin bulk offered by SAFC

    Find a price of Trypan Blue bulk offered by SAFC

    Find a price of Vitamin D3 bulk offered by SAFC

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WISCONSIN. bulk offered by SAFC

    Find a price of EX-CELL 325 PF CHO PROTEIN FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL 525 FOR PER C6 CELLS, DEFINED SERUM FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM(MODIFIED) bulk offered by SAFC

    Find a price of PEG TELOMER B bulk offered by SAFC

    Find a price of CHO ANIMAL-FREE MEDIUM MODIFICATION 21 bulk offered by SAFC

    Find a price of EX-CELL(TM) 325 PF CHO PROTEIN-FREE MEDIUM (MODIFIED) bulk offered by SAFC

    Find a price of 67210 bulk offered by SAFC

    Find a price of STEMMAX(TM), PRODUCT NO. 62647 bulk offered by SAFC

    Find a price of PF-11 bulk offered by SAFC

    Find a price of BIOTAIN-MPS TM CONCENTRATE (100X) bulk offered by SAFC

    Find a price of 1(2PHENYLETHYL)4(N(2PYRAZYL)2(FUROYLAMIDO)PIPERIDINE HCl bulk offered by SAFC

    Find a price of EX-CELL CD HYDROLYSATE FUSION, ANIMAL COMPONENT FREE, CHEMICALLY-DEFINED LIQUID MEDIA, (PRODUCT NO. 14700C), DRY POWDER MEDIA (PRODUCT NO. 24700C) bulk offered by SAFC

    Find a price of STEMLINE™ MESENCHYMAL STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of SERUM-FREE MEDIA SUPPLEMENT PART A (100 X) bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDUIM (MODIFIED), CATALOG NO. 62625 bulk offered by SAFC

    Find a price of ISCOVE'S MODIFIED DULBECCO'S MEDIUM (IMDM) bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFINED SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL PF CHO bulk offered by SAFC

    Find a price of STEMLINE(TM) II HEMATOPOIETIC STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of CHO MEDIUM-ANIMAL COMPONENT-FREE bulk offered by SAFC

    Find a price of PHOSPHATE BUFFERED SALINE (PRODUCT 62137) bulk offered by SAFC

    Find a price of EX-CELL 302 MEDIUM (MODIFIED) CAT. #62630 bulk offered by SAFC

    Find a price of EX-CELL 400 bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) CATALOG NO. 67480 bulk offered by SAFC

    Find a price of 93% DME (HG)/5% NCTC (CAT. NO. 52-589) bulk offered by SAFC

    Find a price of 9-AMINO-1,2,3,4,-TETRAHYDROCRIDINE HCL. (THA) bulk offered by SAFC

    Find a price of STEMLINE(TM) DENDRITIC CELL MATURATION MEDIUM bulk offered by SAFC

    Find a price of SGD-1006 (SG6) bulk offered by SAFC

    Find a price of CHO MEDIUM MODIFICATION 21 bulk offered by SAFC

    Find a price of EX-CELL (TM) 293 MEDIUM bulk offered by SAFC

    Find a price of 2-METHOXYESTRA-3,17 B-DIOL bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM(MODIFIED) bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, MEDIUM, SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL 301 COMPLETE MEDIUM (MODIFIED) bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL (TM) VPRO bulk offered by SAFC

    Find a price of 62180 bulk offered by SAFC

    Find a price of ROSE BENGAL, DISODIUM SALT, SIGMA-ALDRICH CHEMICAL CO. PRODUCT NUMBER W184-3 bulk offered by SAFC

    Find a price of EX-CELL 301 bulk offered by SAFC

    Find a price of EX-CELL 302 MEDIUM (GS MODIFIED), CATALOG NO. 62639 bulk offered by SAFC

    Find a price of DMS-12 (100X) CONCENTRATE bulk offered by SAFC

    Find a price of Q1196-9 bulk offered by SAFC

    Find a price of EX-CELLr ANTIFOAM GAMMA IRRADIATED BY SER-TAINr PROCESS bulk offered by SAFC

    Find a price of HEMOCYANIN FROM KEYHOLE LIMPET bulk offered by SAFC

    Find a price of EX-CELL 325 PF CHO (MODIFIED) PRODUCT NO. 63131 bulk offered by SAFC

    Find a price of STEMLINE NEURAL STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of EX-CELL 610 HSF HYBRIDOMA, SERUM-FREE MEDUIM. CATALOG NO. 14610 bulk offered by SAFC

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search